Clinical Trial: A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation

U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07759154) titled 'A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation' on Aug. 06.

Brief Summary: The primary purpose of this study is to evaluate the efficacy of centanafadine once daily (QD) extended-release (XR) capsules in adults with attention-deficit/hyperactivity disorder (ADHD) and emotional dysregulation (ED).

Study Start Date: Aug. 20

Study Type: INTERVENTIONAL

Condition: Attention-deficit/Hyperactivity Disorder Emotional Dysregulation

Intervention: DRUG: Centanafadine XR

Oral capsules

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Otsuka Pharmaceutical D...